QRX003 Lotion

· Quoin Pharmaceuticals

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for QRX003 Lotion, covering 2025-04-02 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2/3 Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome [Phase 2, Phase 3]